Jazz Pharmaceuticals plc Accounts Payable
Jazz Pharmaceuticals plc (JAZZ) had Accounts Payable of $128.50 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-03
- 2026-06-30: Accounts Payable, Current $128.50M.
- 2026-03-31: Accounts Payable, Current $100.00M.
- 2025-12-31: Accounts Payable, Current $122.10M; Accounts Payable, Current as first filed $122.06M.
- 2025-09-30: Accounts Payable, Current $152.23M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $128.50M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $100.00M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $122.10M 10-Q · filed 2026-08-03 | $122.06M 10-K · filed 2026-02-24 |
| 2025-09-30 | $152.23M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $89.37M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $95.93M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $77.87M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $85.42M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $97.10M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $80.98M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $102.75M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $109.85M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $98.43M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $125.45M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $90.76M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $102.25M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $74.16M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $73.34M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $100.30M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $63.81M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $64.83M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $77.74M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $26.95M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $67.06M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $50.04M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $66.31M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $45.73M 10-K · filed 2021-02-23 | $47.55M 10-K · filed 2020-02-25 |
| 2019-09-30 | $70.10M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $82.22M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $42.67M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $40.60M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $37.37M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $31.38M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $46.93M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $24.37M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $29.97M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $28.53M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $29.14M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $22.41M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $17.63M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $28.41M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $32.62M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $21.81M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $29.12M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $26.41M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $27.32M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $25.13M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $29.67M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $32.55M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $72.54M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $21.00M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $22.43M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $20.37M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $31.63M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $15.89M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $20.54M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $34.51M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $13.69M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $5.13M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $8.46M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $4.67M 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $3.05M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |